Viemed Healthcare, Inc.
VMD· Nasdaq
Released Mar 3, 2020, before the open
10-K filed Mar 4, 2020, 64 days after period end · 0001729149-20-000005
| Metric | Q4 2019 | Q4 2018 |
|---|---|---|
| Revenue | $21.45M | $18.36M |
| Net Income | $2.39M | $2.97M |
| EPS Diluted | $0.06 | $0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Viemed Healthcare, Inc. · CIK 1729149 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2019 · filed Mar 4, 2020 · 64 d after period end
13.2% from the close of Mar 2, 2020 to the close of Mar 4, 2020, the first after the release.